; Entelos Holding Corporation - Strategic SWOT Analysis Review
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Entelos Holding Corporation - Strategic SWOT Analysis Review

VIEWS: 5 PAGES: 22

Entelos Holding Corporation (Entelos), formerly, Entelos, Inc., is a biosimulation company, which offers in silico modeling, simulation software, and related services to the pharmaceutical, healthcare, nutrition and consumer markets. Its consulting services and software are based on its predictive biosimulation technology, PhysioLab. Entelos applies its expertise in physiological mechanistic modeling approach to projects in the therapeutic domains of cardiovascular, hypertension, metabolism, immunology, dermatology, infection, nutrition, and veterinary medicine.

More Info
  • pg 1
									                 Entelos Holding Corporation - Strategic SWOT Analysis Review
        Reference Code: GDPH82352SA                                                                                          Publication Date: JAN 2013

          Two Waters Park Drive, Suite 200                   Phone             +1 650 5725400                   Revenue         NA
          San Mateo, CA                                      Fax               +1 650 5725401                   Net Profit      NA
          94403                                              Website           www.entelos.com                  Employees       NA
                                                                                                                                Pharmaceuticals         &
          United States                                      Exchange                                           Industry
                                                                                                                                Healthcare

       Company Overview
       Entelos Holding Corporation (Entelos), formerly, Entelos, Inc., is a biosimulation company, which offers in silico modeling,
       simulation software, and related services to the pharmaceutical, healthcare, nutrition and consumer markets. Its consulting
       services and software are based on its predictive biosimulation technology, PhysioLab. Entelos applies its expertise in
       physiological mechanistic modeling approach to projects in the therapeutic domains of cardiovascular, hypertension, metabolism,
       immunology, dermatology, infection, nutrition, and veterinary medicine.
       Key Executives                                                             SWOT Analysis
                      Name                               Title                     Entelos Holding Corporation, SWOT Analysis
         Shawn M. O’Connor                 Chief Executive Officer                 Strengths                            Weaknesses
         Art Reidel                        Chairman
                                                                                   Technological Capabilities           Business Challenges
         Steve C. Chang                    Director
                                                                                   Product & Services Offerings
         Prashant Mehrotra                 Director
         Thomas Paterson                   Chief Technology Officer
        Source: Company Website, Primary and Secondary Research,
                                                                                   Opportunities                        Threats
        GlobalData
                                                                                   Business Restructuring               Rapid Technological Change

        Key Competitors                                                            New Business Agreement               Competitive Landscape
         Cyprotex PLC
         Accelrys, Inc.                                                           Source: Company Website, Primary and Secondary Research, GlobalData

         Immunetrics Inc.
         SilicoLife Lda.
        Antitope Ltd.
        Source: Company Website, Primary and Secondary Research,
        GlobalData


       Recent Developments

       Jun 06, 2012                  Entelos Demonstrates Physiolab Predictive Accuracy At American Heart Association Annual Meeting
       Jan 31, 2012                  Entelos Appoints Will Frederick As CFO
       Source: Annual Report, Company Website, Primary and Secondary Research, GlobalData




Entelos Holding Corporation - Strategic SWOT Analysis Review                                                                   Reference Code: GDPH82352SA
Source : www.globalcompanyintelligence.com                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Entelos Holding Corporation - Key Facts............................................................................................................................................ 4
       Entelos Holding Corporation - Key Employees................................................................................................................................... 5
       Entelos Holding Corporation - Key Employee Biographies ................................................................................................................ 6
       Entelos Holding Corporation - Major Products and Services .............................................................................................................. 7
       Entelos Holding Corporation - History ................................................................................................................................................ 8
       Entelos Holding Corporation - Company Statement ......................................................................................................................... 10
       Entelos Holding Corporation - Locations And Subsidiaries .............................................................................................................. 11
          Head Office ................................................................................................................................................................................... 11
       Section 2 – Company Analysis ......................................................................................................................................................... 12
       Entelos Holding Corporation - Business Description ........................................................................................................................ 12
       Entelos Holding Corporation - Corporate Strategy ........................................................................................................................... 13
       Entelos Holding Corporation - SWOT Analysis ................................................................................................................................ 14
          SWOT Analysis - Overview........................................................................................................................................................... 14
          Entelos Holding Corporation - Strengths....................................................................................................................................... 14
             Strength - Technological Capabilities ........................................................................................................................................ 14
             Strength - Product & Services Offerings.................................................................................................................................... 14
          Entelos Holding Corporation - Weaknesses ................................................................................................................................. 14
             Weakness - Business Challenges ............................................................................................................................................. 14
          Entelos Holding Corporation - Opportunities................................................................................................................................. 14
             Opportunity - Business Restructuring ........................................................................................................................................ 14
             Opportunity - New Business Agreement ................................................................................................................................... 15
             Opportunity - Market Prospects: Personalized Medicine ........................................................................................................... 15
          Entelos Holding Corporation - Threats .......................................................................................................................................... 15
             Threat - Rapid Technological Change ....................................................................................................................................... 15
             Threat - Competitive Landscape ............................................................................................................................................... 15
             Threat - Industry Challenges ..................................................................................................................................................... 16
       Entelos Holding Corporation - Key Competitors ............................................................................................................................... 17
       Section 3 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 18
          Entelos Holding Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................... 18
          Entelos Holding Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ............................................... 19
       Entelos Holding Corporation, Recent Deals Summary ..................................................................................................................... 20
       Section 4 – Company’s Recent Developments .........................................................................................
								
To top